Distinguished in Gestational Trophoblastic Disease

Dr. Janos L. Tanyi

Oncology
Penn Medicine
Jordan Center For Gynecologic Cancers
3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
On Staff At
Accepting New Patients
Distinguished in Gestational Trophoblastic Disease
Penn Medicine
Jordan Center For Gynecologic Cancers
3400 Civic Center Boulevard, West Pavilion, 3rd Floor, 
Philadelphia, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Janos Tanyi is an Oncologist in Philadelphia, Pennsylvania. Dr. Tanyi is rated as a Distinguished provider by MediFind in the treatment of Gestational Trophoblastic Disease. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Ovarian Carcinosarcoma, Ureteroscopy, and Bladder Reconstruction. Dr. Tanyi is currently accepting new patients.

His clinical research consists of co-authoring 89 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Medical School Of Debrecen
Residency
Semmelweis University, Medical School
Specialties
Oncology
Licenses
Obstetrics & Gynecology in PA
Board Certifications
Obstetrics And Gynecology - Gynecologic Oncology, 2014
Obstetrics And Gynecology, 2010
Fellowships
Hospital of the University of Pennsylvania
Hospital Affiliations
Hospital Of Univ Of Pennsylvania
Chester County Hospital
Pennsylvania Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Clover Health
  • INSURANCE PLAN
  • MEDICARE MAPD
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Provider Partners Health Plan
  • MEDICARE SNP
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Jordan Center for Gynecologic Cancers
3400 Civic Center Boulevard, West Pavilion, 3rd Floor, Philadelphia, PA 19104
Call: 800-789-7366

Additional Areas of Focus

Dr. Tanyi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Vaginal Cancer
Vulvar Cancer
Cervical Cancer
Gestational Trophoblastic Disease
Ovarian Cysts
Vaginal Cysts
Ovarian Cancer

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin, CTEP-Supplied Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin and CTEP-Supplied Bevacizumab in Platinum Resistant Ovarian Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 02, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Atezolizumab, Bevacizumab, Pegylated liposomal doxorubicin hydrochloride
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
A Phase 3, Randomized, Single Dose, Open-Label Study to Investigate the Safety and Efficacy of OTL38 Injection (OTL38) for Intra-operative Imaging of Folate Receptor Positive Ovarian Cancer
Enrollment Status: Completed
Publish Date: February 04, 2022
Intervention Type: Procedure, Device, Drug
Study Phase: Phase 3
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
FORWARD I: A Randomized, Open Label Phase 3 Study to Evaluate the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) Versus Investigator's Choice of Chemotherapy in Women With Folate Receptor Alpha Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: October 14, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Pilot Trial to Test the Addition of Montanide and Polyiclc to Autologous Oxidized Tumor Cell Lysate Vaccine in Combination With Gmcsf in Primary Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
A Randomized Pilot Trial to Test the Addition of Montanide and Polyiclc to Autologous Oxidized Tumor Cell Lysate Vaccine in Combination With Gmcsf in Primary Advanced Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Enrollment Status: Terminated
Publish Date: April 24, 2020
Intervention Type: Other, Biological
Study Phase: Phase 1
A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination With Epacadostat in Adults With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer
A Phase 1/2, Open-Label Safety and Efficacy Evaluation of CRS-207 in Combination With Epacadostat in Adults With Platinum-Resistant Ovarian, Fallopian, or Peritoneal Cancer
Enrollment Status: Terminated
Publish Date: April 04, 2019
Intervention Type: Drug, Biological
Study Phase: Phase 1/Phase 2
A Pilot Clinical Trial of Dendritic Cell Vaccine Loaded With Autologous Tumor for Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Pilot Clinical Trial of Dendritic Cell Vaccine Loaded With Autologous Tumor for Recurrent Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Enrollment Status: Completed
Publish Date: June 11, 2018
Intervention Type: Biological
Study Phase: Early Phase 1
View 5 Less Clinical Trials

89 Total Publications

Pembrolizumab-associated Guillain-Barre syndrome in a patient with endometrial cancer: A case report.
Pembrolizumab-associated Guillain-Barre syndrome in a patient with endometrial cancer: A case report.
Journal: Gynecologic oncology reports
Published: June 03, 2025
View All 89 Publications
Similar Doctors
Advanced in Gestational Trophoblastic Disease
Dr. John B. Villeneuve
Gynecologic Oncology | Colorectal Surgery | Radiology
Advanced in Gestational Trophoblastic Disease
Dr. John B. Villeneuve
Gynecologic Oncology | Colorectal Surgery | Radiology

Reading Hospital

420 S 5th Ave, Outpatient Services, 
West Reading, PA 
 (47.9 miles away)
484-628-8103
Languages Spoken:
English
See accepted insurances

John Villeneuve is a Gynecologic Oncologist and a Colorectal Surgeon in West Reading, Pennsylvania. Dr. Villeneuve is rated as a Distinguished provider by MediFind in the treatment of Gestational Trophoblastic Disease. His top areas of expertise are Vulvar Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Hysterectomy.

Experienced in Gestational Trophoblastic Disease
Dr. Emily M. Ko
Oncology
Experienced in Gestational Trophoblastic Disease
Dr. Emily M. Ko
Oncology

Penn Gynecologic Oncology Washington Square

800 Walnut Street, 10th Floor, 
Philadelphia, PA 
 (2.0 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Emily Ko is an Oncologist in Philadelphia, Pennsylvania. Dr. Ko is rated as an Elite provider by MediFind in the treatment of Gestational Trophoblastic Disease. Her top areas of expertise are Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Lymphadenectomy, and Salpingo-Oophorectomy. Dr. Ko is currently accepting new patients.

Experienced in Gestational Trophoblastic Disease
Dr. Bethany Bustamante
Oncology
Experienced in Gestational Trophoblastic Disease
Dr. Bethany Bustamante
Oncology

LG Health Physicians Gynecologic Oncology

2102 Harrisburg Pike, 
Lancaster, PA 
 (62.1 miles away)
717-544-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Bethany Bustamante is an Oncologist in Lancaster, Pennsylvania. Dr. Bustamante is rated as an Advanced provider by MediFind in the treatment of Gestational Trophoblastic Disease. Her top areas of expertise are Ovarian Carcinosarcoma, Testicular Yolk Sac Tumor, Endometrial Cancer, Virilizing Ovarian Tumor, and Salpingo-Oophorectomy. Dr. Bustamante is currently accepting new patients.

VIEW MORE GESTATIONAL TROPHOBLASTIC DISEASE DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Tanyi's expertise for a condition
ConditionClose
  • Elite
  • Ovarian Cancer
    Dr. Tanyi is
    Elite
    . Learn about Ovarian Cancer.
    See more Ovarian Cancer experts
  • Distinguished
  • Endometrial Cancer
    Dr. Tanyi is
    Distinguished
    . Learn about Endometrial Cancer.
    See more Endometrial Cancer experts
  • Gestational Trophoblastic Disease
    Dr. Tanyi is
    Distinguished
    . Learn about Gestational Trophoblastic Disease.
    See more Gestational Trophoblastic Disease experts
  • Malignant Mixed Mullerian Tumor
    Dr. Tanyi is
    Distinguished
    . Learn about Malignant Mixed Mullerian Tumor.
    See more Malignant Mixed Mullerian Tumor experts
  • Ovarian Carcinosarcoma
    Dr. Tanyi is
    Distinguished
    . Learn about Ovarian Carcinosarcoma.
    See more Ovarian Carcinosarcoma experts
  • Pseudomyxoma Peritonei
    Dr. Tanyi is
    Distinguished
    . Learn about Pseudomyxoma Peritonei.
    See more Pseudomyxoma Peritonei experts
  • Sertoli-Leydig Cell Tumor
    Dr. Tanyi is
    Distinguished
    . Learn about Sertoli-Leydig Cell Tumor.
    See more Sertoli-Leydig Cell Tumor experts
View All 8 Distinguished Conditions
  • Advanced
  • Angiomyoma
    Dr. Tanyi is
    Advanced
    . Learn about Angiomyoma.
    See more Angiomyoma experts
  • Cervical Cancer
    Dr. Tanyi is
    Advanced
    . Learn about Cervical Cancer.
    See more Cervical Cancer experts
  • Pelvic Congestion Syndrome
    Dr. Tanyi is
    Advanced
    . Learn about Pelvic Congestion Syndrome.
    See more Pelvic Congestion Syndrome experts
  • Vulvar Cancer
    Dr. Tanyi is
    Advanced
    . Learn about Vulvar Cancer.
    See more Vulvar Cancer experts
  • Experienced
  • Adult Soft Tissue Sarcoma
    Dr. Tanyi is
    Experienced
    . Learn about Adult Soft Tissue Sarcoma.
    See more Adult Soft Tissue Sarcoma experts
  • Bladder Reconstruction
    Dr. Tanyi is
    Experienced
    . Learn about Bladder Reconstruction.
    See more Bladder Reconstruction experts
  • BRCA Positive Breast Cancer
    Dr. Tanyi is
    Experienced
    . Learn about BRCA Positive Breast Cancer.
    See more BRCA Positive Breast Cancer experts
  • Breast Cancer
    Dr. Tanyi is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Burkitt Lymphoma
    Dr. Tanyi is
    Experienced
    . Learn about Burkitt Lymphoma.
    See more Burkitt Lymphoma experts
  • Desmoplastic Small Round Cell Tumor
    Dr. Tanyi is
    Experienced
    . Learn about Desmoplastic Small Round Cell Tumor.
    See more Desmoplastic Small Round Cell Tumor experts
View All 22 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.